Transaction

Adenia Partners' Majority Acquisition of Parkville Pharmaceuticals from Admaius Capital Partners and Founders

Announced
26 January 2026
Target
Parkville Pharmaceuticals Egypt Limited
Value
Undisclosed
Asset class
Private Equity
Type
Investment, Exit
Instrument
Equity
Lead investors
Adenia Partners Limited
Investors
Adenia Partners Limited
Sector
Healthcare / Personal Products, Pharmaceuticals
Markets
Egypt

About the target

Parkville Pharmaceuticals Egypt Limited was founded in 2008. Headquartered in Cairo at 11B El Hegaz Square, El-Mohandessin, Infinity Towers, the company operates primarily in Egypt with export operations across Libya, Saudi Arabia, Kuwait, Dubai and Iraq. Core business activities include the development, manufacturing and distribution of pharmaceutical, cosmeceutical and nutraceutical products targeting skin care, hair care, wellness and therapeutic applications. The company manufactures over 125 individual products under multiple brand names, including StarVille, StrongVille, Bobai, Glamy Lab, Shaan, Seropipe, Super Kids and Sulfax.

Sources

  1. www.dailynewsegypt.com
  2. Partner Researchers